Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$8,864 Mln
P/E Ratio
--
P/B Ratio
8.41
Industry P/E
--
Debt to Equity
0.69
ROE
-0.25 %
ROCE
-14.82 %
Div. Yield
0 %
Book Value
19.63
EPS
-5.69
CFO
$1,745.10 Mln
EBITDA
$1,986.44 Mln
Net Profit
$1,672.76 Mln
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
Masimo (MASI)
| -1.31 | -0.25 | -6.87 | 19.83 | 11.32 | -5.15 | 16.69 |
BSE Sensex*
| 2.55 | 3.65 | 4.54 | 7.46 | 12.04 | 19.65 | 11.41 |
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
---|---|---|---|---|---|---|---|
Masimo (MASI)
| 40.63 | -20.78 | -49.47 | 9.09 | 69.80 | 47.21 | 26.45 |
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
---|---|---|---|---|
12.69 | 10,202.62 | 12.01 | 12.69 | |
72.33 | 10,025.34 | 96.83 | 2.52 | |
66.16 | 8,163.79 | 21.5 | 11.07 | |
296.91 | 11,513.99 | 277.87 | 3.65 |
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through... motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arterial oxygen saturation, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow respiratory support therapy, neuromodulation technology, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California. Address: 52 Discovery, Irvine, CA, United States, 92618 Read more
Founder, CEO & Chairman
Mr. Joseph E. Kiani
Founder, CEO & Chairman
Mr. Joseph E. Kiani
Headquarters
Irvine, CA
Website
The total asset value of Masimo Corporation (MASI) stood at $ 2,626 Mln as on 31-Dec-24
The share price of Masimo Corporation (MASI) is $163.14 (NASDAQ) as of 29-Apr-2025 16:00 EDT. Masimo Corporation (MASI) has given a return of 11.32% in the last 3 years.
Masimo Corporation (MASI) has a market capitalisation of $ 8,864 Mln as on 29-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Masimo Corporation (MASI) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Masimo Corporation (MASI) and enter the required number of quantities and click on buy to purchase the shares of Masimo Corporation (MASI).
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arterial oxygen saturation, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow respiratory support therapy, neuromodulation technology, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California. Address: 52 Discovery, Irvine, CA, United States, 92618
The CEO & director of Mr. Joseph E. Kiani. is Masimo Corporation (MASI), and CFO & Sr. VP is Mr. Joseph E. Kiani.
There is no promoter pledging in Masimo Corporation (MASI).
Some of the close peers are:
Company | Market Cap($ Mln) |
---|---|
1,078
|
|
1,054
|
|
964
|
|
802
|
Masimo Corporation (MASI) | Ratios |
---|---|
Return on equity(%)
|
-25.23
|
Operating margin(%)
|
-12.5
|
Net Margin(%)
|
-14.56
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Masimo Corporation (MASI) was $0 Mln.